According to Coherent Market Insights, the cannabidiol market was valued at around USD 9.46 billion in 2025. It is expected to grow at a compound annual growth rate (CAGR) of 16.5% until 2032, and its value could reach USD 27.57 billion. Hemp accounts for approximately 58% of the market, and CBD remains the most prevalent and widely marketed.
With evidence-based therapeutic benefits, CBD products are part of the wellness industry and are available in various formulations. Among them, CBD isolates consistently experience a decline in market share relative to broad-spectrum and full-spectrum CBD.
Why is the purest cannabinoid lagging behind other forms? In this comprehensive guide, gain insights into the key market dynamics and driving forces.
Composition of CBD Products
Hemp Compounds
The hemp plant contains various cannabinoids, including CBG and CBD. Moreover, it contains several terpenes that are well known for their mood-regulating and pain-relieving properties. Other than terpenes and cannabinoids, hemp does have THC, such as delta-9 THC and delta-8 THC, but in smaller proportions than marijuana.
Full Spectrum and Broad Spectrum
In this market, CBD products that contain all hemp compounds are labeled as full-spectrum CBD. These products do contain THC, but only up to 0.3% on a dry-weight basis, as permitted under federal law.
Likewise, broad-spectrum CBD contains most hemp compounds except THC. These products are preferred by those who want to experience the therapeutic effects of non-intoxicating cannabinoids.
CBD Isolates
Products that contain only CBD, with all other cannabinoids extracted with CO₂ extraction and filtered out, give rise to CBD isolates. These products are not earthy in taste like other common CBD products, and also guarantee zero THC due to rigorous refining steps.
Factors Behind Lower CBD Isolates Market Share
Despite the high concentration of CBD, the demand for isolates is much lower and continues to lose market share day by day. Although their use is common among beginners, most experienced consumers prefer full-spectrum or broad-spectrum products.
1. Cannabis Synergy (Entourage Effect)
Different cannabinoids, when combined with terpenes, work more effectively in terms of therapeutic outcomes. This phenomenon is known as the entourage effect or cannabis synergy.
The therapeutic properties of cannabis-based medicinal extracts are much higher than those of concentrated CBD. Various phytocannabinoid-terpenoid combinations have shown promising results in managing symptoms of conditions such as:
-
Pain and inflammation
-
Mental issues
-
Drug addiction
-
Epilepsy
-
Cancer
As a result, consumers seeking a holistic wellness approach tend to prefer whole hemp extracts rather than isolated CBD alone.
2. Slow Healing
CBD itself has therapeutic potential, making it a significant wellness compound. However, when taken alone, CBD isolate often produces slower results compared to formulations combined with other cannabinoids and terpenes. Individuals seeking quick relief hesitate to use isolated CBD, as it typically requires consistent dosing over an extended period.
According to a study, broad-spectrum CBD is more effective in managing symptoms of depression, anxiety, and pain than CBD isolate. When CBD isolate and broad-spectrum CBD are consumed at equivalent concentrations, broad-spectrum products tend to deliver more effective and noticeable outcomes due to synergistic interactions among compounds.
3. Price Consideration
In terms of value against cost, CBD isolates are relatively expensive, as consumers are paying a premium price for a single, specific cannabinoid. Manufacturers often charge the similar prices comparable to other CBD products due to the additional refinement and filtration steps involved in producing isolates.
On the other hand, within the same price range, consumers can experience better therapeutic effects from broad-spectrum and full-spectrum products. As a result, these formulations are generally perceived as more valuable than CBD isolates.
4. Reliable Brands Access
Brands offering CBD isolates are comparatively fewer than those providing broad- or full-spectrum CBD products. Low demand is one major factor behind the limited availability, but cost considerations also play a role. CBD isolates require more filtration and refinement than other formulations. Their production costs are higher and demand greater infrastructure and investment.
Moreover, some brands falsely label their products as CBD isolates while actually containing other compounds. Therefore, it is essential to choose brands that provide third-party lab testing and a clear Certificate of Analysis before declaring it as pure CBD.
5. Potential Side Effects
No doubt, CBD isolates are safer than other CBD products when obtained from a reliable source. The chances of side effects are minimal with such wellness products. However, this does not mean they are completely risk-free. Individual responses to CBD can vary, and some people may experience issues such as:
-
Digestive problems
-
Sudden changes in appetite
-
Fatigue or tiredness
-
Weight fluctuations
-
Sleep disturbance
Like other CBD products, it is recommended to start with a small dose to allow the body to adapt. Since the therapeutic potential of isolates is limited and the effects take longer to appeal, many users consider the struggle not worth it.
Legal Landscape of CBD Isolates
Despite their declining market share, CBD isolates are the only products with a guaranteed future in terms of legal perspective. With the new hemp bill passed in November 2025, which will come into effect in November 2026, many CBD products may face potential legal challenges regarding their compliance.
Amid this uncertainty, CBD isolates offer a clearer legal picture, as they contain only non-psychoactive CBD without any THC or other cannabinoids. This is why individuals who continue to use isolates are beginners exploring a CBD wellness approach. Or, they are users concerned about legal compliance and differences in state and federal laws.
Potential Market Trends of CBD Isolate
Currently, CBD isolates hold a significant market share, but their share is lower than that of others. With a shift from traditional to complementary treatment therapies, full- and broad-spectrum CBD products are gaining more traction.
Factors such as cannabis synergy, faster results, better value for cost, and easy accessibility are shaping consumer trends of the cannabinoid market. However, these products are also facing legal challenges due to evolving federal regulations and testing requirements for hemp.
So, what does the future hold for CBD isolates? Consumers can expect some significant market changes as the industry continues to evolve.
